Corrigendum to "The PIKASO trial (Preventing Injured Knees from Osteoarthritis: Severity Outcomes): Rationale and design features for a randomized controlled trial" [Osteoarthr Cartil Open 7 (2025) 100563]. [PDF]
Jacobs CA +34 more
europepmc +1 more source
Mentor, driving force and companion for healthcare research. [PDF]
Bierbaum T +3 more
europepmc +1 more source
Antihypertensive medication is not associated with increased disease severity in atopic dermatitis in the TREATgermany registry. [PDF]
Hollstein MM +4 more
europepmc +1 more source
A Real-world Meta-analysis Study of Disease Severity in European Patients Who Received Baricitinib for Atopic Dermatitis: Data from BioDay, SCRATCH and TREATgermany. [PDF]
Boesjes C +16 more
europepmc +1 more source
Association between procalcitonin and mortality in patients with necrotizing fasciitis: A single-center retrospective study. [PDF]
Bingoel AS +6 more
europepmc +1 more source
Label-free in vivo molecular profiling of the human retina by non-resonant Raman spectroscopy. [PDF]
Sentosa R +15 more
europepmc +1 more source
Motor- and cognitive-dominant functional network adaptations supporting dual-task performance in older adults. [PDF]
Deng Y +7 more
europepmc +1 more source
VEGFR2 deletion increases susceptibility to photoreceptor degeneration through glial-neuronal interaction. [PDF]
Bielmeier CB +12 more
europepmc +1 more source
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany. [PDF]
Heinrich L +26 more
europepmc +1 more source
Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry. [PDF]
Kind B +4 more
europepmc +1 more source

